nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—Irinotecan—stomach cancer	0.571	1	CbGbCtD
Gallamine Triethiodide—Haemoglobin—Fluorouracil—stomach cancer	0.00116	0.00296	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Fluorouracil—stomach cancer	0.00116	0.00296	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Fluorouracil—stomach cancer	0.00115	0.00295	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Fluorouracil—stomach cancer	0.00115	0.00293	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Irinotecan—stomach cancer	0.00112	0.00286	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Docetaxel—stomach cancer	0.0011	0.00281	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Epirubicin—stomach cancer	0.00109	0.00278	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Methotrexate—stomach cancer	0.00108	0.00276	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Docetaxel—stomach cancer	0.00108	0.00275	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Capecitabine—stomach cancer	0.00106	0.00272	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Capecitabine—stomach cancer	0.00104	0.00266	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Methotrexate—stomach cancer	0.00102	0.0026	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Epirubicin—stomach cancer	0.00101	0.00258	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Doxorubicin—stomach cancer	0.001	0.00257	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Docetaxel—stomach cancer	0.000987	0.00252	CcSEcCtD
Gallamine Triethiodide—Anaemia—Irinotecan—stomach cancer	0.000968	0.00248	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Capecitabine—stomach cancer	0.000965	0.00247	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Capecitabine—stomach cancer	0.000956	0.00244	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Epirubicin—stomach cancer	0.000951	0.00243	CcSEcCtD
Gallamine Triethiodide—Malaise—Irinotecan—stomach cancer	0.000945	0.00242	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Irinotecan—stomach cancer	0.000938	0.0024	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Doxorubicin—stomach cancer	0.000935	0.00239	CcSEcCtD
Gallamine Triethiodide—Anaemia—Fluorouracil—stomach cancer	0.000928	0.00237	CcSEcCtD
Gallamine Triethiodide—Cough—Irinotecan—stomach cancer	0.000914	0.00234	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Fluorouracil—stomach cancer	0.000898	0.0023	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Doxorubicin—stomach cancer	0.00088	0.00225	CcSEcCtD
Gallamine Triethiodide—Confusional state—Irinotecan—stomach cancer	0.000862	0.0022	CcSEcCtD
Gallamine Triethiodide—Chest pain—Fluorouracil—stomach cancer	0.000854	0.00218	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Irinotecan—stomach cancer	0.000837	0.00214	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Docetaxel—stomach cancer	0.000836	0.00214	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Docetaxel—stomach cancer	0.000834	0.00213	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Docetaxel—stomach cancer	0.000832	0.00213	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Docetaxel—stomach cancer	0.000828	0.00212	CcSEcCtD
Gallamine Triethiodide—Confusional state—Fluorouracil—stomach cancer	0.000826	0.00211	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.000811	0.00207	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Capecitabine—stomach cancer	0.00081	0.00207	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Capecitabine—stomach cancer	0.000808	0.00207	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Capecitabine—stomach cancer	0.000806	0.00206	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Fluorouracil—stomach cancer	0.000802	0.00205	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Capecitabine—stomach cancer	0.000802	0.00205	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Fluorouracil—stomach cancer	0.000799	0.00204	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Docetaxel—stomach cancer	0.000778	0.00199	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Docetaxel—stomach cancer	0.000772	0.00197	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Irinotecan—stomach cancer	0.000768	0.00196	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Capecitabine—stomach cancer	0.000753	0.00193	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000751	0.00192	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Capecitabine—stomach cancer	0.000748	0.00191	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000746	0.00191	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Methotrexate—stomach cancer	0.000742	0.0019	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Epirubicin—stomach cancer	0.000741	0.00189	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000738	0.00189	CcSEcCtD
Gallamine Triethiodide—Fatigue—Irinotecan—stomach cancer	0.000737	0.00189	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Fluorouracil—stomach cancer	0.000735	0.00188	CcSEcCtD
Gallamine Triethiodide—Pain—Irinotecan—stomach cancer	0.000731	0.00187	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Epirubicin—stomach cancer	0.000725	0.00186	CcSEcCtD
Gallamine Triethiodide—Abdominal discomfort—Methotrexate—stomach cancer	0.000718	0.00184	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Methotrexate—stomach cancer	0.000712	0.00182	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Docetaxel—stomach cancer	0.000709	0.00181	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000707	0.00181	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Irinotecan—stomach cancer	0.000705	0.0018	CcSEcCtD
Gallamine Triethiodide—Pain—Fluorouracil—stomach cancer	0.0007	0.00179	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Epirubicin—stomach cancer	0.000694	0.00178	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Capecitabine—stomach cancer	0.000687	0.00176	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—stomach cancer	0.000686	0.00175	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Irinotecan—stomach cancer	0.000676	0.00173	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Irinotecan—stomach cancer	0.000676	0.00173	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Fluorouracil—stomach cancer	0.000675	0.00173	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—stomach cancer	0.000671	0.00172	CcSEcCtD
Gallamine Triethiodide—Anaemia—Docetaxel—stomach cancer	0.000669	0.00171	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Epirubicin—stomach cancer	0.000666	0.0017	CcSEcCtD
Gallamine Triethiodide—Urticaria—Fluorouracil—stomach cancer	0.000651	0.00166	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Docetaxel—stomach cancer	0.000648	0.00166	CcSEcCtD
Gallamine Triethiodide—Anaemia—Capecitabine—stomach cancer	0.000648	0.00166	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Fluorouracil—stomach cancer	0.000647	0.00166	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—stomach cancer	0.000642	0.00164	CcSEcCtD
Gallamine Triethiodide—Malaise—Capecitabine—stomach cancer	0.000632	0.00162	CcSEcCtD
Gallamine Triethiodide—Cough—Docetaxel—stomach cancer	0.000632	0.00162	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Irinotecan—stomach cancer	0.00063	0.00161	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Capecitabine—stomach cancer	0.000628	0.00161	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Docetaxel—stomach cancer	0.000617	0.00158	CcSEcCtD
Gallamine Triethiodide—Chest pain—Docetaxel—stomach cancer	0.000617	0.00158	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—stomach cancer	0.000616	0.00158	CcSEcCtD
Gallamine Triethiodide—Asthenia—Irinotecan—stomach cancer	0.000614	0.00157	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000612	0.00157	CcSEcCtD
Gallamine Triethiodide—Cough—Capecitabine—stomach cancer	0.000612	0.00156	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Fluorouracil—stomach cancer	0.000603	0.00154	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Methotrexate—stomach cancer	0.000603	0.00154	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methotrexate—stomach cancer	0.0006	0.00153	CcSEcCtD
Gallamine Triethiodide—Chest pain—Capecitabine—stomach cancer	0.000597	0.00153	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Capecitabine—stomach cancer	0.000597	0.00153	CcSEcCtD
Gallamine Triethiodide—Confusional state—Docetaxel—stomach cancer	0.000596	0.00152	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000593	0.00152	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Irinotecan—stomach cancer	0.000585	0.0015	CcSEcCtD
Gallamine Triethiodide—Pruritus—Fluorouracil—stomach cancer	0.000579	0.00148	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Docetaxel—stomach cancer	0.000579	0.00148	CcSEcCtD
Gallamine Triethiodide—Confusional state—Capecitabine—stomach cancer	0.000577	0.00148	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Docetaxel—stomach cancer	0.000577	0.00148	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Docetaxel—stomach cancer	0.000574	0.00147	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—stomach cancer	0.000564	0.00144	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—stomach cancer	0.000563	0.00144	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—stomach cancer	0.000561	0.00144	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methotrexate—stomach cancer	0.00056	0.00143	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Fluorouracil—stomach cancer	0.00056	0.00143	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Capecitabine—stomach cancer	0.00056	0.00143	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Capecitabine—stomach cancer	0.000559	0.00143	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—stomach cancer	0.000558	0.00143	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methotrexate—stomach cancer	0.000557	0.00142	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Capecitabine—stomach cancer	0.000556	0.00142	CcSEcCtD
Gallamine Triethiodide—Vomiting—Irinotecan—stomach cancer	0.000544	0.00139	CcSEcCtD
Gallamine Triethiodide—Rash—Irinotecan—stomach cancer	0.000539	0.00138	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Irinotecan—stomach cancer	0.000539	0.00138	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000539	0.00138	CcSEcCtD
Gallamine Triethiodide—Headache—Irinotecan—stomach cancer	0.000536	0.00137	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Docetaxel—stomach cancer	0.000531	0.00136	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—stomach cancer	0.000525	0.00134	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—stomach cancer	0.000522	0.00133	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000521	0.00133	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—stomach cancer	0.000521	0.00133	CcSEcCtD
Gallamine Triethiodide—Vomiting—Fluorouracil—stomach cancer	0.000521	0.00133	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—stomach cancer	0.000521	0.00133	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—stomach cancer	0.000519	0.00133	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—stomach cancer	0.000517	0.00132	CcSEcCtD
Gallamine Triethiodide—Rash—Fluorouracil—stomach cancer	0.000516	0.00132	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Fluorouracil—stomach cancer	0.000516	0.00132	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Capecitabine—stomach cancer	0.000514	0.00131	CcSEcCtD
Gallamine Triethiodide—Headache—Fluorouracil—stomach cancer	0.000513	0.00131	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Methotrexate—stomach cancer	0.000511	0.00131	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00051	0.00131	CcSEcCtD
Gallamine Triethiodide—Fatigue—Docetaxel—stomach cancer	0.00051	0.0013	CcSEcCtD
Gallamine Triethiodide—Nausea—Irinotecan—stomach cancer	0.000508	0.0013	CcSEcCtD
Gallamine Triethiodide—Pain—Docetaxel—stomach cancer	0.000506	0.00129	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000494	0.00126	CcSEcCtD
Gallamine Triethiodide—Fatigue—Capecitabine—stomach cancer	0.000493	0.00126	CcSEcCtD
Gallamine Triethiodide—Pain—Capecitabine—stomach cancer	0.000489	0.00125	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Docetaxel—stomach cancer	0.000487	0.00125	CcSEcCtD
Gallamine Triethiodide—Nausea—Fluorouracil—stomach cancer	0.000487	0.00124	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—stomach cancer	0.000485	0.00124	CcSEcCtD
Gallamine Triethiodide—Anaemia—Methotrexate—stomach cancer	0.000483	0.00123	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—stomach cancer	0.000482	0.00123	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—stomach cancer	0.000478	0.00122	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Capecitabine—stomach cancer	0.000472	0.00121	CcSEcCtD
Gallamine Triethiodide—Malaise—Methotrexate—stomach cancer	0.000471	0.0012	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Docetaxel—stomach cancer	0.000467	0.0012	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Docetaxel—stomach cancer	0.000467	0.0012	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Methotrexate—stomach cancer	0.000467	0.00119	CcSEcCtD
Gallamine Triethiodide—Cough—Methotrexate—stomach cancer	0.000456	0.00116	CcSEcCtD
Gallamine Triethiodide—Urticaria—Capecitabine—stomach cancer	0.000455	0.00116	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Capecitabine—stomach cancer	0.000452	0.00116	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Capecitabine—stomach cancer	0.000452	0.00116	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—stomach cancer	0.000452	0.00115	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methotrexate—stomach cancer	0.000444	0.00114	CcSEcCtD
Gallamine Triethiodide—Chest pain—Methotrexate—stomach cancer	0.000444	0.00114	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—stomach cancer	0.000443	0.00113	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000441	0.00113	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—stomach cancer	0.000441	0.00113	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—stomach cancer	0.000437	0.00112	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Docetaxel—stomach cancer	0.000436	0.00111	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methotrexate—stomach cancer	0.00043	0.0011	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—stomach cancer	0.000426	0.00109	CcSEcCtD
Gallamine Triethiodide—Asthenia—Docetaxel—stomach cancer	0.000424	0.00108	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Capecitabine—stomach cancer	0.000422	0.00108	CcSEcCtD
Gallamine Triethiodide—Pruritus—Docetaxel—stomach cancer	0.000418	0.00107	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—stomach cancer	0.000418	0.00107	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Methotrexate—stomach cancer	0.000417	0.00107	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—stomach cancer	0.000416	0.00106	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—stomach cancer	0.000416	0.00106	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methotrexate—stomach cancer	0.000414	0.00106	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000413	0.00106	CcSEcCtD
Gallamine Triethiodide—Asthenia—Capecitabine—stomach cancer	0.000411	0.00105	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—stomach cancer	0.000408	0.00104	CcSEcCtD
Gallamine Triethiodide—Pruritus—Capecitabine—stomach cancer	0.000405	0.00104	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—stomach cancer	0.000405	0.00103	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Docetaxel—stomach cancer	0.000404	0.00103	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—stomach cancer	0.000402	0.00103	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—stomach cancer	0.000394	0.00101	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Capecitabine—stomach cancer	0.000392	0.001	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—stomach cancer	0.00039	0.000998	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—stomach cancer	0.000389	0.000995	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000388	0.000993	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—stomach cancer	0.000387	0.00099	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—stomach cancer	0.000385	0.000984	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—stomach cancer	0.000385	0.000984	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methotrexate—stomach cancer	0.000383	0.000978	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000382	0.000977	CcSEcCtD
Gallamine Triethiodide—Vomiting—Docetaxel—stomach cancer	0.000376	0.000961	CcSEcCtD
Gallamine Triethiodide—Rash—Docetaxel—stomach cancer	0.000373	0.000953	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Docetaxel—stomach cancer	0.000372	0.000952	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—stomach cancer	0.000372	0.000951	CcSEcCtD
Gallamine Triethiodide—Headache—Docetaxel—stomach cancer	0.00037	0.000947	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000368	0.000941	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methotrexate—stomach cancer	0.000367	0.000939	CcSEcCtD
Gallamine Triethiodide—Pain—Methotrexate—stomach cancer	0.000364	0.000932	CcSEcCtD
Gallamine Triethiodide—Vomiting—Capecitabine—stomach cancer	0.000364	0.000931	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000363	0.000929	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000361	0.000924	CcSEcCtD
Gallamine Triethiodide—Rash—Capecitabine—stomach cancer	0.000361	0.000923	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Capecitabine—stomach cancer	0.000361	0.000922	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—stomach cancer	0.00036	0.000921	CcSEcCtD
Gallamine Triethiodide—Headache—Capecitabine—stomach cancer	0.000359	0.000917	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—stomach cancer	0.000358	0.000916	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—stomach cancer	0.000358	0.000916	CcSEcCtD
Gallamine Triethiodide—Nausea—Docetaxel—stomach cancer	0.000351	0.000898	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methotrexate—stomach cancer	0.000351	0.000898	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000344	0.00088	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—stomach cancer	0.000344	0.000879	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—stomach cancer	0.000341	0.000872	CcSEcCtD
Gallamine Triethiodide—Nausea—Capecitabine—stomach cancer	0.00034	0.000869	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methotrexate—stomach cancer	0.000338	0.000866	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methotrexate—stomach cancer	0.000337	0.000861	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Methotrexate—stomach cancer	0.000337	0.000861	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000336	0.00086	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—stomach cancer	0.000331	0.000847	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—stomach cancer	0.000329	0.00084	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000319	0.000814	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—stomach cancer	0.000318	0.000813	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—stomach cancer	0.000317	0.00081	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—stomach cancer	0.000316	0.000807	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—stomach cancer	0.000315	0.000806	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—stomach cancer	0.000315	0.000806	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methotrexate—stomach cancer	0.000314	0.000803	CcSEcCtD
Gallamine Triethiodide—Asthenia—Methotrexate—stomach cancer	0.000306	0.000782	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—stomach cancer	0.000304	0.000777	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methotrexate—stomach cancer	0.000301	0.000771	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—stomach cancer	0.000294	0.000751	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—stomach cancer	0.000293	0.000749	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—stomach cancer	0.000292	0.000746	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—stomach cancer	0.000292	0.000746	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methotrexate—stomach cancer	0.000292	0.000745	CcSEcCtD
Gallamine Triethiodide—Asthenia—Epirubicin—stomach cancer	0.000286	0.000732	CcSEcCtD
Gallamine Triethiodide—Pruritus—Epirubicin—stomach cancer	0.000282	0.000721	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Epirubicin—stomach cancer	0.000273	0.000698	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—stomach cancer	0.000272	0.000695	CcSEcCtD
Gallamine Triethiodide—Vomiting—Methotrexate—stomach cancer	0.000271	0.000693	CcSEcCtD
Gallamine Triethiodide—Rash—Methotrexate—stomach cancer	0.000269	0.000687	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methotrexate—stomach cancer	0.000268	0.000686	CcSEcCtD
Gallamine Triethiodide—Headache—Methotrexate—stomach cancer	0.000267	0.000683	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—stomach cancer	0.000265	0.000677	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—stomach cancer	0.000261	0.000667	CcSEcCtD
Gallamine Triethiodide—Vomiting—Epirubicin—stomach cancer	0.000254	0.000648	CcSEcCtD
Gallamine Triethiodide—Nausea—Methotrexate—stomach cancer	0.000253	0.000647	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—stomach cancer	0.000252	0.000646	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—stomach cancer	0.000251	0.000643	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—stomach cancer	0.000251	0.000642	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—stomach cancer	0.00025	0.000639	CcSEcCtD
Gallamine Triethiodide—Nausea—Epirubicin—stomach cancer	0.000237	0.000606	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—stomach cancer	0.000235	0.0006	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—stomach cancer	0.000233	0.000595	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—stomach cancer	0.000232	0.000594	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—stomach cancer	0.000231	0.000591	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—stomach cancer	0.000219	0.00056	CcSEcCtD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000127	0.00335	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HRH4—stomach cancer	0.000126	0.00333	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—PRKCB—stomach cancer	0.000126	0.00332	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CDX2—stomach cancer	0.000125	0.00331	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GMPR2—stomach cancer	0.000123	0.00325	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPL13—stomach cancer	0.000123	0.00325	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPL18—stomach cancer	0.000123	0.00325	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—AGTR2—stomach cancer	0.000121	0.0032	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000119	0.00313	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000117	0.0031	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—HTR1A—stomach cancer	0.000117	0.00308	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPS21—stomach cancer	0.000115	0.00303	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPS15—stomach cancer	0.000115	0.00303	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.000113	0.003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—ANXA1—stomach cancer	0.000113	0.00297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—KISS1—stomach cancer	0.000113	0.00297	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—IDH3B—stomach cancer	0.000112	0.00297	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SUCLG1—stomach cancer	0.000112	0.00297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.000112	0.00297	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000112	0.00297	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.000111	0.00293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL10—stomach cancer	0.000108	0.00286	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.000108	0.00286	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	0.000107	0.00282	CbGpPWpGaD
Gallamine Triethiodide—ACHE—ATF-2 transcription factor network—IL6—stomach cancer	0.000107	0.00281	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MUC2—stomach cancer	0.000107	0.00281	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NDUFS1—stomach cancer	0.000105	0.00276	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NDUFV1—stomach cancer	0.000105	0.00276	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—FGFR2—stomach cancer	0.000103	0.00272	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000102	0.0027	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000101	0.00268	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.000101	0.00267	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	0.000101	0.00266	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—KISS1R—stomach cancer	9.87e-05	0.00261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	9.63e-05	0.00254	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	9.52e-05	0.00251	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	9.38e-05	0.00248	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PGLS—stomach cancer	9.32e-05	0.00246	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BLVRB—stomach cancer	9.32e-05	0.00246	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPL15—stomach cancer	9.31e-05	0.00246	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—HSPD1—stomach cancer	9.31e-05	0.00246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	9.27e-05	0.00245	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	9.02e-05	0.00238	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KISS1R—stomach cancer	8.96e-05	0.00237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	8.95e-05	0.00236	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPAP2A—stomach cancer	8.89e-05	0.00235	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCB—stomach cancer	8.72e-05	0.0023	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPS26—stomach cancer	8.69e-05	0.00229	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	8.67e-05	0.00229	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	8.55e-05	0.00226	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—MAPK1—stomach cancer	8.45e-05	0.00223	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—APC—stomach cancer	8.34e-05	0.0022	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	8.2e-05	0.00216	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FBP1—stomach cancer	7.92e-05	0.00209	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NDUFA2—stomach cancer	7.92e-05	0.00209	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CKB—stomach cancer	7.92e-05	0.00209	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CA1—stomach cancer	7.92e-05	0.00209	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGFBP3—stomach cancer	7.87e-05	0.00208	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	7.82e-05	0.00206	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—PRKCB—stomach cancer	7.77e-05	0.00205	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	7.64e-05	0.00202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6R—stomach cancer	7.47e-05	0.00197	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLIN2—stomach cancer	7.45e-05	0.00197	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPS19—stomach cancer	7.39e-05	0.00195	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGTR2—stomach cancer	7.33e-05	0.00194	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—PAX6—stomach cancer	7.31e-05	0.00193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—F2R—stomach cancer	7.25e-05	0.00191	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CA2—stomach cancer	7.25e-05	0.00191	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	7.24e-05	0.00191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HRH4—stomach cancer	7.13e-05	0.00188	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NT5E—stomach cancer	7.06e-05	0.00186	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PGAM1—stomach cancer	7.06e-05	0.00186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—HTR1A—stomach cancer	7.06e-05	0.00186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	7.02e-05	0.00185	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—RHOA—stomach cancer	7e-05	0.00185	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	6.91e-05	0.00182	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	6.89e-05	0.00182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ANXA1—stomach cancer	6.82e-05	0.0018	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—HRAS—stomach cancer	6.78e-05	0.00179	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALDH7A1—stomach cancer	6.74e-05	0.00178	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLCE1—stomach cancer	6.74e-05	0.00178	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	6.68e-05	0.00176	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB1—stomach cancer	6.6e-05	0.00174	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—RPS6—stomach cancer	6.53e-05	0.00172	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	6.52e-05	0.00172	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—stomach cancer	6.48e-05	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRH4—stomach cancer	6.48e-05	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—MAPK1—stomach cancer	6.47e-05	0.00171	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—UMPS—stomach cancer	6.46e-05	0.00171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—KISS1—stomach cancer	6.36e-05	0.00168	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—PIK3CA—stomach cancer	6.1e-05	0.00161	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	6.02e-05	0.00159	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PDHA1—stomach cancer	6e-05	0.00159	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ECHS1—stomach cancer	6e-05	0.00159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—CXCL8—stomach cancer	5.92e-05	0.00156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KISS1—stomach cancer	5.77e-05	0.00152	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	5.7e-05	0.0015	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL1B—stomach cancer	5.68e-05	0.0015	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TYMP—stomach cancer	5.65e-05	0.00149	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FADS1—stomach cancer	5.65e-05	0.00149	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	5.54e-05	0.00146	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—JUN—stomach cancer	5.51e-05	0.00145	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RGS2—stomach cancer	5.47e-05	0.00144	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—GAST—stomach cancer	5.47e-05	0.00144	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	5.42e-05	0.00143	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	5.42e-05	0.00143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB2—stomach cancer	5.35e-05	0.00141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KISS1R—stomach cancer	5.29e-05	0.0014	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GLI3—stomach cancer	5.29e-05	0.0014	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SREBF2—stomach cancer	5.29e-05	0.0014	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	5.22e-05	0.00138	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—RORA—stomach cancer	5.22e-05	0.00138	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—HRAS—stomach cancer	5.2e-05	0.00137	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	5.16e-05	0.00136	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	5.12e-05	0.00135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RBP1—stomach cancer	5.05e-05	0.00133	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—GAST—stomach cancer	4.97e-05	0.00131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RGS2—stomach cancer	4.97e-05	0.00131	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALDOB—stomach cancer	4.89e-05	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—VEGFA—stomach cancer	4.81e-05	0.00127	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—stomach cancer	4.72e-05	0.00125	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.7e-05	0.00124	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.62e-05	0.00122	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.61e-05	0.00122	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALOX5—stomach cancer	4.55e-05	0.0012	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	4.55e-05	0.0012	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—stomach cancer	4.49e-05	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—stomach cancer	4.49e-05	0.00119	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—DPYD—stomach cancer	4.48e-05	0.00118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—stomach cancer	4.27e-05	0.00113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—stomach cancer	4.24e-05	0.00112	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—HRAS—stomach cancer	4.19e-05	0.00111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR2—stomach cancer	4.14e-05	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—stomach cancer	4.12e-05	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WWOX—stomach cancer	4.12e-05	0.00109	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—F2R—stomach cancer	4.1e-05	0.00108	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.06e-05	0.00107	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—MAPK1—stomach cancer	4e-05	0.00106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—HTR1A—stomach cancer	3.99e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTT1—stomach cancer	3.96e-05	0.00105	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2A6—stomach cancer	3.91e-05	0.00103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	3.9e-05	0.00103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ANXA1—stomach cancer	3.85e-05	0.00102	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRH4—stomach cancer	3.83e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WIF1—stomach cancer	3.83e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKR1C3—stomach cancer	3.81e-05	0.00101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR2—stomach cancer	3.76e-05	0.000994	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB1—stomach cancer	3.73e-05	0.000985	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—F2R—stomach cancer	3.72e-05	0.000983	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ENO1—stomach cancer	3.71e-05	0.00098	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.65e-05	0.000963	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HTR1A—stomach cancer	3.62e-05	0.000956	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKAB1—stomach cancer	3.53e-05	0.000933	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ANXA1—stomach cancer	3.5e-05	0.000924	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RNF43—stomach cancer	3.41e-05	0.000901	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KISS1—stomach cancer	3.41e-05	0.000901	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	3.39e-05	0.000896	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB1—stomach cancer	3.39e-05	0.000895	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—stomach cancer	3.33e-05	0.000878	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD44—stomach cancer	3.29e-05	0.000869	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP2—stomach cancer	3.22e-05	0.00085	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—HRAS—stomach cancer	3.21e-05	0.000849	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.19e-05	0.000843	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FST—stomach cancer	3.04e-05	0.000803	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB2—stomach cancer	3.02e-05	0.000798	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HBEGF—stomach cancer	2.97e-05	0.000785	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GAST—stomach cancer	2.93e-05	0.000775	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RGS2—stomach cancer	2.93e-05	0.000775	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPP2R1A—stomach cancer	2.8e-05	0.000739	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGG—stomach cancer	2.78e-05	0.000734	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB2—stomach cancer	2.75e-05	0.000725	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTP1—stomach cancer	2.74e-05	0.000725	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—stomach cancer	2.71e-05	0.000715	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PPP2R1A—stomach cancer	2.69e-05	0.00071	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKAA1—stomach cancer	2.68e-05	0.000707	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—stomach cancer	2.68e-05	0.000706	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RBP4—stomach cancer	2.58e-05	0.000683	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—stomach cancer	2.58e-05	0.000682	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TYMS—stomach cancer	2.55e-05	0.000674	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—stomach cancer	2.52e-05	0.000666	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ERCC2—stomach cancer	2.37e-05	0.000626	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—stomach cancer	2.23e-05	0.000588	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HSPB1—stomach cancer	2.22e-05	0.000587	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR2—stomach cancer	2.22e-05	0.000587	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BMP2—stomach cancer	2.2e-05	0.00058	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—F2R—stomach cancer	2.2e-05	0.00058	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKR1C3—stomach cancer	2.16e-05	0.000571	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HTR1A—stomach cancer	2.14e-05	0.000565	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PRKCB—stomach cancer	2.07e-05	0.000547	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ANXA1—stomach cancer	2.07e-05	0.000546	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAV1—stomach cancer	2.06e-05	0.000543	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—APOA1—stomach cancer	2.05e-05	0.000542	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB1—stomach cancer	2e-05	0.000529	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.96e-05	0.000519	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RPS6—stomach cancer	1.91e-05	0.000505	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	1.88e-05	0.000497	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	1.87e-05	0.000495	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PPARG—stomach cancer	1.81e-05	0.000477	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HBEGF—stomach cancer	1.76e-05	0.000464	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6R—stomach cancer	1.67e-05	0.000441	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	1.66e-05	0.000439	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—stomach cancer	1.62e-05	0.000429	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB2—stomach cancer	1.62e-05	0.000428	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	1.59e-05	0.00042	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—stomach cancer	1.55e-05	0.00041	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RHOA—stomach cancer	1.51e-05	0.000399	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SMAD4—stomach cancer	1.48e-05	0.00039	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	1.46e-05	0.000386	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—stomach cancer	1.42e-05	0.000375	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FYN—stomach cancer	1.4e-05	0.00037	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	1.33e-05	0.00035	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGFR2—stomach cancer	1.32e-05	0.000347	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IRS2—stomach cancer	1.2e-05	0.000318	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CAV1—stomach cancer	1.17e-05	0.000308	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APOA1—stomach cancer	1.17e-05	0.000308	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRKCB—stomach cancer	1.11e-05	0.000293	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6ST—stomach cancer	1.11e-05	0.000292	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APC—stomach cancer	1.06e-05	0.000281	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	1.02e-05	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6R—stomach cancer	9.88e-06	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	9.69e-06	0.000256	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—stomach cancer	9.69e-06	0.000256	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	9.26e-06	0.000245	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	9.25e-06	0.000244	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—stomach cancer	9.15e-06	0.000242	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RHOA—stomach cancer	8.92e-06	0.000236	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—stomach cancer	8.83e-06	0.000233	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—stomach cancer	8.75e-06	0.000231	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	8.41e-06	0.000222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB2—stomach cancer	8.26e-06	0.000218	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—stomach cancer	7.83e-06	0.000207	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRAS—stomach cancer	7.78e-06	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	7.65e-06	0.000202	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—stomach cancer	7.45e-06	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCND1—stomach cancer	7.3e-06	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUN—stomach cancer	7.28e-06	0.000192	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—stomach cancer	7.08e-06	0.000187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	7.06e-06	0.000186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK8—stomach cancer	6.89e-06	0.000182	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—stomach cancer	6.36e-06	0.000168	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—stomach cancer	6.3e-06	0.000166	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK3—stomach cancer	6.02e-06	0.000159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—stomach cancer	5.85e-06	0.000155	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK1—stomach cancer	5.73e-06	0.000151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—stomach cancer	5.72e-06	0.000151	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—stomach cancer	5.41e-06	0.000143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	4.97e-06	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—stomach cancer	4.81e-06	0.000127	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRAS—stomach cancer	4.6e-06	0.000121	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—stomach cancer	4.4e-06	0.000116	CbGpPWpGaD
